Baird Medical Investment Holdings Ltd（BDMD）财务数据BDMDBaird Medical Investment Holdings Ltd

Evaluating the bottom line, Baird Medical Investment Holdings Ltd maintains a gross margin of 86.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.54%, while the net margin is 0.14%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively BDMD converts its operational activities into shareholder value.

In the context of the broader market, BDMD competes directly with industry leaders such as CDIO and VNRX. With a market capitalization of $5.04M, it holds a significant position in the sector. When comparing efficiency, BDMD's gross margin of 86.97% stands against CDIO's 100.00% and VNRX's 100.00%. Such benchmarking helps identify whether Baird Medical Investment Holdings Ltd is trading at a premium or discount relative to its financial performance.

The company reported a net income of -$15,984,110 in Q1 2026 and a gross margin of 84.71%, which is declining from previous periods. The total revenue for Q2 2026 was $9,915,407, indicating significant revenue challenges.